CMC project management of 5+ projects (Biosimilars, 2nd generation biopharmaceuticals, cytokines, hormones, monoclonal antibodiesthereof 4 already EMA licensed)
Type II variation of blockbuster biopharmaceutical downstream process
Member of the industrial advisoryboardsfor biotechnology of the University of Applied ScienceMannheim and for Life Science
Management at HTW University Berlin
...we do not have the "answer to the ultimate Question of Life, the Universe, and Everything" but at least the right house number...